Τόμος 22 (2004) – Τεύχος 3 – Άρθρο 3 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 22 (2004) – Issue 2 – Article 3 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

 

Τίτλος – Title

Σακχαρώδης Διαβήτης Τύπου 1  και Εφηβεία

Adolescence and Diabetes Mellitus Type 1

Συγγραφέας – Author

Άννα Δελτσίδου1, Χρήστος Μπαρτσόκας2, Χρυσούλα Λεμονίδου2, Βασιλική Μάτζιου2

1 Τμήμα Νοσηλευτικής, Τεχνολογικό Εκπαιδευτικό Ίδρυμα Λαμίας, Λαμία, Ελλάς 2 Τμήμα Νοσηλευτικής, Εθνικό και Καποδιστριακό Πανεπιστήμιον Αθηνών, Αθήνα, Ελλάς

A. Deltsidou1, Ch. Bartsokas2, Chr. Lemonidou2, Vas. Matziou2

1 Nursing Department, Technological Educa­tional Institution of Lamia (TEI), Lamia, Greece 2 Nursing Department, Kapodistrian University of Athens, Athens, Greece

Παραπομπή – Citation

  Δελτσίδου,Α., Μπαρτσόκας,Χ., Λεμονίδου,Χ., Μάτζιου,Β. : Σακχαρώδης Διαβήτης Τύπου 1  και Εφηβεία, Επιθεώρηση Κλιν. Φαρμακολ. Φαρμακοκινητ. 22: 123-133 (2004)

Deltsidou,Α., Bartsokas,Ch., Lemonidou,Chr., Matziou,Vas. : Adolescence and Diabetes Mellitus Type 1, Epitheorese Klin. Farmakol. Farmakokinet. 22: 123-133 (2004)

Ημερομηνία Δημοσιευσης – Publication Date
10 Μαΐου 2004 – 2004-05-10
Γλώσσα Πλήρους Κειμένου –
Full Text Language

Ελληνικά – Greek

Παραγγελία – Αγορά –
Order – Buy
Ηλεκτρονική Μορφή: pdf (15 €)
Digital Type: pdf (15 )
pharmakonpress[at]pharmakonpress[.]gr
Λέξεις κλειδιά – Keywords
Σακχαρώδης διαβήτης τύπου 1, εφηβεία, εκπαίδευση, θεραπευτική αντιμετώπιση, διατροφή του παιδιού, ινσουλίνη, διαταραχή των γονάδων
Diabetes mellitus type 1, adolescence, education, treatment of children, nutrition, insulin administration, gonadal dysfunction
Λοιποί Όροι – Other Terms

Άρθρο

Article

Περίληψη – Summary

Ο Σακχαρώδης Διαβήτης (ΣΔ) είναι σύνδρομο το οποίο χαρακτηρίζεται από διαταραχές του μετα­βολισμού των υδατανθράκων, των λιπών και των λευκωμάτων, με ετερογενές και πολυπαραγοντικό αιτιολογικό υπόστρωμα, που δεν έχει μέχρι σήμε­ρα πλήρως διευκρινισθεί. Ο Σακχαρώδης Διαβήτης Τύπου 1 (ΣΔΤ1) είναι η πιο συχνή ενδοκρινική διαταραχή της παιδικής ηλικίας. Κάθε χρόνο υπολογίζεται, ότι 10.000 παιδιά και έφηβοι κάτω των 15 ετών νο­σούν στην Ευρώπη από ΣΔΤ1. Στην Ελλάδα, σύμ­φωνα με τα στοιχεία που υπάρχουν μέχρι αυτή τη στιγμή, η ετήσια εμφάνιση νέων περιπτώσεων ΣΔΤ1 είναι περίπου 10 σε 100.000 παιδιά μικρότερα των 14 ετών στην πε­ριοχή της Ατ-τικής και 5-7/100.000 στην επαρχία. Η εφηβεία είναι ιδιαίτερα δύσκολη περίοδος για το άτομο με διαβήτη, ενώ ο κατάλληλος χειρισμός αυτής της μεταβατικής περιόδου είναι πολύ σημαντικός  για την πρόληψη επιπλοκών, που πολλές φορές είναι εμφανείς από την εφηβεία. Από τη μελέτη της διεθνούς βιβλιογραφίας διαπιστώνεται αυξημένη συχνότητα διαταραχών του εμμηνορρυσιακού κύκλου στις γυναίκες που πάσχουν από ΣΔΤ1 και καθυστέρηση στην εμμηναρχή, σε σχέση με τον υπόλοιπο πληθυσμό. Η ομάδα διαβήτη πρέπει να διδάξει και να εκπαιδεύσει τα παιδιά με διαβήτη, τους εφήβους, καθώς και τις οι­κογένειές τους. Η εκπαίδευση πρέπει να περιλαμβά­νει τις υπάρχουσες γνώσεις για την αιτιολογία, την κληρονομικότητα, την ινσουλίνη, τη διατροφή, τα συμπτώματα, τη θεραπεία, τον αυτοέλεγχο, τις ο­ξείες και τις χρόνιες επιπλοκές. Η τριάδα ινσουλίνη, διατροφή και άσκηση αποτελούν τη βάση της εκπαίδευσης κάθε παιδιού ή εφήβου με διαβήτη, καθώς και της οικογένειάς του, για να επιτευχθεί η καλύτερη δυνατή ρύθμι­ση.

Diabetes Mellitus is a syndrome char­acterized by disorders of the metabolism of carbo­hydrates, of lipids and of proteins with a hetero­genic and multifactorial causative background, not com­pletely defined up to this day. Diabetes Mellitus Type 1 is the most common endocrine disorder of childhood. It is estimated that 10.000 children and adolescents per year, younger than the age of 15, manifest Diabetes Mellitus Type 1 disease in Europe. In Greece according the data up to this day, the annual manifestation of new cases of children with Diabetes Mellitus Type 1 is about 10/100.000 children younger than the age of 14, in the wide area of Attica and 5-7/100.000 in the county. Ado­lescence is, a particularly difficult period for the in­dividual with diabetes, so, the appropriate man­agement of this transitional phase is very impor­tant for the prevention of the complications manifested several times in adolescence. From the study of lit­erature it is ascertained an increased frequency of menstrual disorders in women with Diabetes Mel­litus and delayed menarche, in comparison with women without diabetes. The team care has to educate ado­lescents with diabetes, such as their families. Educa­tion must include the existing knowl­edge for the cause, the heredity, the insulin admini­stration, the nutrition, the symptoms, the treatment, and the self-control of diabetes, the acute and chronic complications. The triad, insulin, nutrition and physical exercise constitute the base of the education of children or adolescents with diabetes, such as their families, for better regula­tion of dia­betes.

Αναφορές – References
1. Πλέσσας Σ.Τ.: Ειδικές δίαιτες σε ασθενείς με σακχαρώδη διαβήτη. Σε: Ειδικές Δίαιτες, Σ.Τ. Πλέσσας, εκδ.). Σελ. 72-91, Εκδόσεις Φάρμακον-Τύπος, Αθήνα, 1994

2. Τούντας Χ.: Σακχαρώδης Διαβήτης- Θεωρία και Πράξη. Εκδόσεις Επτάλοφος, Αθήνα, 1995

3. Μπαρτσόκας Χ.: Ο Διαβήτης στα Παιδιά και τους Εφήβους. Σε: Σακχαρώδης Διαβήτης: Θεωρία και Πράξη (Τούντας Χ., Εκδ.). σελ. 158-168, Εκδόσεις Επτάλοφος, Αθήνα, 1995

4. American Diabetes Association: Care of children with diabetes in the school and day care setting.Diabetes Care (position statement) 25(Suppl. 1): S122–S126 (2002)

5. Bryden K.S., Peveler R.C., Stein A., Neil A., FRCP, Mayou R.A., Dunger D.B.: Clinical and psychological course of diabetes from adolescence to young adulthood. A longitudinal cohort study. Diabetes Care 24: 1536-1540 (2001)

6. Rother K.I., Levitsky L.L.: Diabetes during adolescence. Endocrinol. Metab. Clin. North Am. 22: 553-572 (1993)

7. Schroeder B., Hertweek S.P., Sanfilippo J.S., Foster M.B.: Correlation between glycemic control and menstrua­tion in diabetic adolescents.J. Reprod. Med. 45(1): 1-5 (2000)

8. Bergqvist N.: The gonadal function in female diabetics. Acta Endocrinol. 19 (Suppl.): 3-20 (1954)

9. Burkart W., Fischer-Gunternhöner E., Standl E., Schneider H.P.G.: Menarche, Zyklus und Fertilität bei der Diabetikerin. Geburtshilfe Frauenheilkd. 49: 149-154 (1989)

10. Gens E., Michaelis D.: The frequency of disturbances of somatic development in young people with type 1 diabetes in dependence on duration and age at onset of the dis­ease. Clin. Endocrinol. 95: 97-104 (1990)

11. Cawood E.H.H., Bancroft J., Steel J.M.: Perimenstrual symptoms in women with diabetes mellitus and the rela­tionship to diabetic control. Med. 10: 444-448 (1993)

12. Yeshaya A., Orvieto R., Dicker D., Karp M., Ben- Raphael Z.: Menstrual characteristics of women suffering from insulin- dependent diabetes mellitus. Int. J. Fertil. Menopausal Stud. 40: 269-273 (1995)

13. Μπατρίνος Μ.Λ.: Σύγχρονη Ενδοκρινολογία. Σελ. 342-399, Εκδόσεις Πασχαλίδη, Αθήνα, 1982

14. Bjork S.: The cost of diabetes and diabetes care. Dia­betes Res. Clin. Pract. 54 (Suppl.1): S13-8 (2001)

15. Icks A., Rosenbauer J., Holl R.W., Grabert M., Rath­mann W., Giani G.: On behalf of the German Working Group for Pediatric Diabetology: Hospitalization among diabetic children and adolescents and the general popula­tion in Germany. Diabetes Care 24: 435-440 (2001)

16. Songer T.J.: The role of cost-effectiveness analysis and health insurance in diabetes care. Diabetes Res. Clin. Pract. 54 (Suppl. 1): S7-11 (2001)

17. Bennett P.H.: Definition, diagnosis, and classification of diabetes mellitus and impaired glucose tolerance. In: Joslin’ s Diabetes Mellitus (Kahn R., Weir G.C., eds). 13th ed. Pp. 193-200, Lea & Febiger, Pennsylvania, 1994

18. Μητράκου Α.: Σακχαρώδης διαβήτης: Παθοφυσιολογία σακχαρώδη διαβήτη. Σε: Βασική Ενδοκρινολογία (Κούτρας Δ., Αδαμόπουλος Δ., Ράπτης Σ., Σουβατζόγλου Α., Εκδ.). Σελ. 914-924, Γ. Παρισιάνος,  Αθήνα, 1994

19. Fajans S.S.: Classification and diagnosis of diabe­tes.In: Ellenberg & Rifkin’s Diabetes Mellitus (Porte D., Sherwin R., eds). 5th ed. Pp.357-372, Appleton & Lange, Connecticut, 1997

20. American Diabetes Association: Evidence-based nutri­tion principles and recommendations for the treatment and prevention of diabetes and related complications (position statement). Diabetes Care 26: S51-S61 (2003)

21. Fajans S.S., Cloutier M.C., Crowther R.L.: Clinical and etiological heterogeneity of idiopathic diabetes mellitus (Banting Memorial Lecture). Diabetes 27: 1112-1125 (1978)

22. Παυλάτος Φ.: Σακχαρώδης Διαβήτης. Σε: Σακχαρώδης Διαβήτης: Θεωρία και Πράξη (Τούντας Χ., Εκδ.). Σελ.133-157, Εκδόσεις Επτάλοφος, Αθήνα, 1995

23. Καραμάνος Β.: Ετήσια Μετεκπαιδευτικά Μαθήματα για τον Σακχαρώδη Διαβήτη. σελ. 27-47, Αθήνα, 2001

24. WorldHealthOrganization: ReportoftheWHOexpertCommitteeonDiabetes Mellitus. Geneva: WHO 646: 1-80 (1980)

25. Kaufmann F.R.: Type 2 diabetes mellitus in children and youth: a new epidemic. J. Pediatr. Endocrinol. Metab. 15: 737-744 (2002)

26. Μπαρτσόκας Χ.: Ο τύπος 2 διαβήτη στα παιδιά και τους εφήβους. Θεραπευτικήπροσέγγιση. Ιατρική 82(συμπλήρωμα): 55-60 (2002)

27. Arslanian S., Danadian K.: Insulin secretion, insulin sensitivity and diabetes in black children. Trends Endocri­nol. Metab. 9:194-199 (1998)

28. Libman I.M., Laporte R.E., Becker D.J., et al.: Was there an epidemic of diabetes in nonwhite adolescents in Allegheny County, Pennsylvania? Diabetes Care 21: 1278-1281 (1998)

29. Neufeld N.D., Raffel L.J., Landon C., et al.: Early pres­entation of type 2 diabetes in Mexican-Amercan youth. Diabetes Care 21: 89-96 (1998)

30. Dabelea D., Pettitt D.J., Jones K.L., et al.: Type 2 Diabetes Mellitus in minority children and adolescents: An emerging problem. Endocrinol. Metab. Clin. North Am. 28: 709-729 (1999)

31. Danadian K., Balasekaran G., Lewy V., et al.: Insulin sensitivity in African-American children with and without family history of type 2 diabetes. Diabetes Care 22: 1325-1329 (1999)

32. World Health Organization:Diabetes Mellitus. Report of a WHO study group. Geneva: WHO 727: 1-113 (1985)

33. Fajans S.S.: Maturity-onset diabetes of the young (MODY). Diabetes Metab. Rev. 5: 579-606 (1989)

34. FajansS.S.: Scope and heterogenous nature of ma­turity-onset diabetes of the young (MODY). Diabetes Care 13: 49-64 (1990)

35. Fajans S.S., Bell G.I., Bowden D.W., et al.: Maturity- onset diabetes of the young. Life Sci. 55: 413 (1994)

36. Frayling T.M., Lindgren C.M., Chevre J.C., Menzel S., Wishart M., Benmezroua Y., Brown A., Evans J.C., Rao P.S., Dina C., Lecoeur C., Kanninen T., Almgren P., Bul­man M.P., Wang Y., Mills J., Wright-Pascoe R., Mahtani M.M., Prisco F., Costa A., Cognet I., Hansen T., Pedersen O., Ellard S., Tuomi T., Groop L.C., Froguel P., Hattersley A.T., Vaxillaire M.: A genome-wide scan in families with maturity-onset diabetes of the young. Diabetes 52: 872-881 (2003)

37. Winter W.E., Maclaren N.K., Riley W.J., Clarke D.W., Kappy M.S., Spillar P.: Maturity-onset diabetes of youth in black Americans. N. Engl. J. Med. 316: 285-291 (1987)

38. Chiu K.C., Province M.A., Permutt M.A.: Glucokinase gene is genetic marker for NIDDM in American Blacks. Diabetes 41: 843 (1992)

39. Hattersley A.T., Turner R.C., Permutt M.A., et al.: Linkage of type II diabetes to the glukokinase gene. Lancet 339: 1307 (1992)

40. Velho G., Froguel P., Clement K., Pueyo M.E., Rako­toambinina B., Zouali H., Passa P., Cohen D., Robert J.J.: Primary pancreatic b-cell secretory defect caused by mu­tations in glucokinase gene in kindreds of maturity onset diabetes of the young.Lancet 340:444-448 (1992)

41. Unger R.H., Foster D.W.:Diabetes Mellitus. Textbook of Endocrinology (Wilson J., Foster D., Kronenberg H., Larsen P.R., eds). 9th ed. Pp.973-1059, W.B. Saunders Company, Philadelphia, 1998

42. American Diabetes Association: Tests of Glycemia in Diabetes (position statement). Diabetes Care 27: S91-S93 (2004)

43. Μoran A., Jacobs D.R., Steinberger J., Hong C-P., Prineas R., Luepker R., Sinaiko A.R.: Insulin resistance during puberty. Results from Clamp Studies in children. Diabetes 48: 2 039-2044 (1999)

44. Irwin C.E: Adolescent Social Behavior and Health. Jossey-Bass, San Francisco, 1987

45. Simmons R.G.: Social transition and adolescent devel­ In: Adolescent Social Behavior and Health, (Irvin C.E., ed.). Pp. 33-62, Jossey-Bass, San Francisco, 1987

46. Sargeant D.T., Achyenberg J., Davis J.E.: Increased haemoglobin A1c in insulin dependent during puberty. Diabetes 29 ( Suppl. 2): 177A (1980)

47. Amiel S.A., Sherwin R.S., Simonson D.C., Lauritano A.A., Tamborlane W.V.: Impaired insulin action in puberty: A contributing factor to poor glycemic control in adoles­cents with diabetes. N. Engl. J. Med. 315: 215-219 (1986)

48. Bloch C.A., Clemons P.S., Sperling M.A.: Puberty de-creases insulin sensitivity. Pediatr. 110: 481-487 (1987)

49. Mortensen H.B., Hartling S.G., Petersen K.E.: A na­tion-wide cross-sectional study of glycosylated haemoglo­bin in Danish children with type 1 diabetes. Diabet. Med. 5: 871-876 (1988)

50. Amiel S.A., Caprio S., Sherwin R.S., Plewe G., Hay­mond M.W., Tamborlane W.V.: Insulin resistance of pu­berty: a defect restricted to peripheral glucose metabolism. Clin. Endocrinol .Metab. 72: 277-282 (1988)

51. Aman J., Kroon M., Jones I., Segnestam K., Snellman K.: Urinary growth hormone excretion in post-menarcheal adolescent girls with type 1 diabetes. Acta Paediatr. 87: 149-153 (1998)

52. Walsh C.H., Malins J.M.: Menstruation and control of diabetes. BMJ 16: 177-179 (1977)

53. Mann N.P., Johnston D.I.: Improvement in metabolic control in diabetic adolescents by the use of increased insulin dose. Diabetes Care 7: 460-464 (1984)

54. Magos A., Studd J.: Effects of the menstrual cycle on medical disorders. Br. J. Hosp. Med. 33: 68-77 (1985)

55. Smith C.P., Archibald H.R., Thomas J.M., Tarn A.C., WilliamsA.J., Gale E.A., Savage M.O.: Basal and stimu­lated insulin levels rise with advancing puberty. Clin. En­docrinol. 28: 7-14 (1988)

56. Brown K.G.E., Darby C.W., Ng S.H.: Cyclical distur­bance of diabetic control in girls before the menarche. Dis. Child. 66: 1279-1281 (1991)

57. Τσαγκαράκης Σ., Θαλασσινός Ν.: Σακχαρώδης διαβήτης και ορμόνες. Σε: Σακχαρώδης Διαβήτης: Θεωρία και Πράξη (Τούντας Χ., Εκδ.). Σελ. 95-106, Εκδόσεις Επτάλοφος, Αθήνα, 1995

58. Lunt H., Brown L.J.: Self-reported changes in capillary glucose and insulin requirements during the menstrual cycle.Diabet. Med. 13: 525-530 (1996)

59. Goran M.I., Gower B.A.: Longitudinal study on pubertal insulin resistance. Diabetes 50: 2444-2450 (2001)

60. American Diabetes Association: Insulin Administration (position statement). Diabetes Care 26: S121-S124 (2003)

61. Hill J.P.: Research on adolescents and their families: Past and prospect. In: Adolescent Social Behavior and Health (Irwin C.E., ed.). Pp.13-32, Jossey-Bass, San Francisco, 1987

62. Baumrind D.: A developmental perspective on adoles­cent risk taking in contemporary America. In: Adolescent Social Behavior and Health (Irwin C.E., ed.). P93-126, Jossey-Bass, San Francisco, 1987

63. Soltesz G.: Diabetes in the young: a paediatric and epidemiological perspective. Diabetologia 46: 447-454 (2003)

64. Thernlund G., Dahlquist G., Hägglöf B., Ivarsson S.A., Lernmark B., Ludvigsson J., Sjöblad S.: Psychological reactions at the onset of insulin-dependent diabetes mel­litus in children and later adjustment and metabolic control. Acta Paediatr. 85: 947-953 (1996)

65. Blethen S.L., Sargeant D.T., Whitlow M.G., et al.: Ef­fect of pubertal age and recent blood glucose control on plasma somatomedin in children with insulin-dependent diabetes mellitus. Diabetes 30: 868-873 (1981)

66. Daneman D., Wolfson D.H., Becker D.J., Drash A.L.: Factors affecting glycosylated hemoglobin values in chil­dren with insulin-dependent diabetes. J. Pediatr. 99: 847-853 (1981)

67. Cerreto M.C., Tavis L.B.: Implications of psychological factors in the treatment of diabetes. Clin. North Am. 31: 689-710 (1984)

68. American Diabetes Association: Summary of Revisions for the 2004 Clinical Practice Recommendations (position statement). Diabetes Care 27: S3 (2004)

69. ISPAD Guidelines: ISPAD Consensus Guidelines for the Management of Type 1 Diabetes Mellitus in Children and Adolescents. Medical Forum International, 2000

70. American Diabetes Association: Third-Party Reim­bursement for Diabetes Care, Self-Management Educa­tion, and Supplies (position statement). Diabetes Care 27: S136-S137 (2004)

71. Citrin W., Tapp J.T., Wine H.E.: Diabetes Counseling Issues: The Patient and The Family. In: Pediatric and Adolescent Diabetes Mellitus (Brink S.J., ed.). Pp. 369-399, Year Book Medical Publishers, Chicago, 1987

72. Anderson B.J., Laffel L.M.B.: Behavioral and family aspects of the treatment of children and adolescents with insulin-dependent diabetes mellitus. In: Ellenberg & Rifkin’s Diabetes Mellitus (Porte D., Sherwin R., eds). 5th, pp.811-826, Appleton & Lange, Connecticut, 1997

73. Laron Z., Galatzer A., et al.: A multidisciplinary, com­prehensive, ambulatory treatment scheme for diabetes mellitus in children.Diabetes Care 2: 342-348 (1979)

74. Tamborlane W.V., Gatcomb P.M., Held N.A., et al.: Type I diabetes in children. In: Therapy for Diabetes Mel­litus and Related Disorders (Lebovitz H., ed.). 2nd ed., pp. 46-52, VA: American Diabetes Association, Alexandria, 1994

75. Wolfsdorf J.I., Anderson B.A., Pasquarello C.: Treat­ment of child with diabetes. In: Joslin’s Diabetes Mellitus (Kahn C.R., Weir G., eds). 13th ed, 430-451, Lea & Febiger, Philadelphia, 1994

76. Glasgow R.E.: A practical model of diabetes manage­ment and education. Diabetes Care 18: 117–126 (1995)

77. Munro N., Felton A., McIntosh C.: Is multidisciplinary learning effective among those caring for people with dia­betes? Diabet. Med. 19: 799-803 (2002)

78. Vallis M., Ruggiero L., Greene G., Jones H., Zinman B., Rossi S., Edwards L., Rossi J.S., Prochaska J.O.: Stages of change for healthy eating in diabetes. Relation to demographic, eating-related, health care utilization, and psychosocial factors. Diabetes Care 26:1468-1474 (2003)

79. American Diabetes Association: Third-Party Reim­bursement for Diabetes Care, Self-Management Educa­tion, and Supplies (position statement). Diabetes Care 26: S143-S144 (2003)

80. Grey M., Boland E.A., Yu C., Sullivan-Bolyai S., Tamborlane W.: Personal and family factors associated with quality of life in adolescents with diabetes. Diabetes Care 21: 909-914 (1998)

81. Χαρσούλης Φ.: Κλινική Ενδοκρινολογία. Σελ. 390-494, University Studio Press, Θεσσαλονίκη, 1998

82. American Diabetes Association: Nutrition Principles and Recommendations in Diabetes (position statement). Diabetes Care 27: S36 (2004)

83. Marre M., Sauvanet J.P.: What allows a type 1 diabetic to be well controlled. Diabetes Metab. 28 (4 Pt 2): 2S7-2S14 (2002)

84. Koev D.J., Tankova T.I., Kozlovski P.G.: Effect of structured group education on glycemic control and hypo­glycemia in insulin-treated patients. Diabetes Care 26: 251 (2003)

85. Hanaire-BroutinH.: Insulin therapy and self-monitoring of blood glucose: therapeutic management and recommendations. Diabetes Metab. 29(2 Pt 2): S21-5 (2003)

86. Robert J.J.: Blood glucose monitoring in the manage­ment of type 1diabetes in childhood. Diabetes Metab. 29(2): S47-53 (2003)

87. Scherbaum W.A.: Insulin therapy in Europe. Diabetes Metab. Res. Rev. 18 (Supplement) 3: S50-56 (2002)

88. American Diabetes Association: Physical Activ­ity/Exercise and Diabetes Mellitus (position statement). Diabetes Care 26: S73-S77 (2003)

89. American Diabetes Association: Physical Activ­ity/Exercise and Diabetes (position statement). Diabetes Care 27: S58-S62 (2004)

90. Kinmonth A.L., Magrath G., Reckless J.P.D., et al.: Dietary recommendations for children and adolescents with diabetes.Diabet. Med. 6: 537 (1989)

91. Brink S.J.: Pediatric and adolescent nutrition issues: Glycemic index, fiber, lipids, sodium, and other nutrient controversies in insulin-dependent Diabetes Mellitus. In: Pediatric and Adolescent Diabetes Mellitus (Brink S.J., ed.). Pp. 273-303, Year Book Medical Publishers, Chi­cago, 1987

92. Turner B.C., Jenkins E., Kerr D., Sherwin R.S., Cavan D.A.: The Effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes. Diabetes Care 24: 1888-1893 (2001)

93. Raile K., Kapellen T., Schweiger A., Hunkert F., Nietzschmann U., Dost A., Kiess W.: Physical activity and competitive sports in children and adolescents with type 1 diabetes. Diabetes Care 22: 1904 (1999)

94. Fuchsjager-Mayrl G., Pleiner J., Wiesinger G.F., Sieder A.E., Quittan M., Nuhr M.J., Francesconi C., Seit H.P., Francesconi M., Schmetterer L., Wolzt M.: Exercise training improves vascular endothelial function in patients with type 1 diabetes. Diabetes Care 25:1795-1801 (2002)

95. Wagener D.K., Sacks J.M., LaPorte R.E., MacGregor J.M.: The Pittsburgh study of insulin-dependent diabetes mellitus. Risk for diabetes among relatives of IDDM. Dia­betes 31: 136-144 (1982)

96. Cook T.C., Laporte R.E., Washburn R.A., et al.: Chronic low-level physical activity as a determinant of high density lipoprotein cholesterol and subfractions. Sci. Sports Exerc. 18: 653 (1986)

97. Biankin S.A., Jenkins A.B., Campbell L.V., Choi K.M., Forrest Q.G., Chisholm D.J.: Target-seeking behavior of plasma glucose with exercise in type 1 diabetes. Diabetes Care 26: 297-301 (2003)

98. Brink S.J.: Exercise for children and adolescents with insulin-dependent Diabetes Mellitus. In: Pediatric and Adolescent Diabetes Mellitus (Brink S.J., ed.). Pp. 323-341, Year Book Medical Publishers, Chicago, 1987

99. Yamanouchi K., Abe R., Takeda A., Atsumi Y., Shichiri M., Sato Y.: The effect of walking before and after break­fast on blood glucose levels in patients with type 1 diabe­tes treated with intensive insulin therapy. Diabetes Res. Clin. Pract. 58(1): 11-18 (2002)

100. Trzeciak B.: The effect of diabetes mellitus on the incidence of abnormal genital bleeding in women. Ginekol. Pol. 49: 119-123 (1978)

101. Djursing H., Nyholm H.C., Hagen C., Carstensen L., Pedersen L.M.: Clinical and hormonal characteristics in women with anovulation and insulin-treated diabetes mel­litus. J. Obstet. Gynecol. 143: 876-882 (1982)

102. Kjaer K., Hagen C., Sando S.H., Eshoj O.: Epidemi­ology of menarche and menstrual disturbances in an un­selected group of women with insulin-dependent diabetes mellitus compared to controls. Clin. Endocrinol. Metab. 75: 524-529 (1992)

103. Levitsky L.L.: Growth and pubertal pattern in insulin dependent diabetes mellitus. Semin. Adolesc. Med. 3: 233 (1987)

104. Sherman L.D., Rogers D.G., Gabbay K.H., et al.: Pulsatility of luteinizing hormone during puberty is de­pendent on recent glycemic control. Adolesc. Pediatr. Gynecol. 4: 87 (1991)

105. South S.A., Asplin C.M., Carlsen E.C., Booth R.A., Weltman J.Y., Johnson M.L., Veldhuis J.D., Evans W.S.: Alterations in luteinizing hormone secretory activity in women with insulin-dependent diabetes mellitus and sec­ondary amenorrhea. J. Clin. Endocrinol. Metab. 76: 1048-1053 (1993)

106. Adcock C.J., Perry L.A., Lindsell D.R.M., Taylor A.M., Holly J.M.P., Jones J., Dunger D.B.: Menstrual irregulari­ties are more common in adolescents with type 1 diabetes: association with poor glycaemic control and weight gain.Diabet. Med. 11(5): 465-470 (1994)

107. Griffin M.L., South S.A., Yankov V.I., Booth R.A., Asplin C.M., Veldhuis J.D., Evans W.S.: Insulin- dependent diabetes mellitus and menstrual dysfunction. Ann. Med. 26: 331-340 (1994)

108. Daneman D., Drash A.L., Lobes LA., Becker D.J., Baker L.M., Travis L.B.: Progressive retinopathy with im­proved control in diabetic dwarfism (Mauriac’s syndrome). Diabetes Care 4: 360 (1981)

109. Dunger D.B., Edge J.A., Pal R., Taylor A.M., Holly J.M.P., Matthews DR.: Impact of increased growth hor­mone secretion on carbohydrate metabolism in adoles­cents with diabetes. Acta Paediatr. Suppl. 377: 69-71 (1991)

110. Tattersall R.B., Pyke D.A.: Growth in diabetic chil­dren. Studies in identical twins. Lancet 2: 1105-1109 (1973)

111. Salardi S., Tonioli S., Tassoni P., et al.: Growth and growth factors in diabetes mellitus. Arch. Dis. Child. 62: 57 (1987)

112. Αδαμόπουλος Δ.: Ήβη. Σε: Βασική Ενδοκρινολογία (Κούτρας Δ., Αδαμόπουλος Δ., Ράπτης Σ.,  Σουβατζόγλου Α., Εκδ.). Σελ. 481-504, Γ. Παρισιάνος, Αθήνα, 1994

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:
Chemical Abstracts

Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor

Articles published in this Journal are Indexed or Abstracted in:
• Chemical Abstracts
• Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ – ANNUAL SUBSCRIPTION
Γλώσσα Πλήρους Κειμένου –
Full Text Language
Ελληνικά – Greek
Παραγγελία – Αγορά –
Order – Buy
Ηλεκτρονική Μορφή: pdf (70 €) –
Digital Type: pdf (70 €)
pharmakonpress[at]pharmakonpress[.]gr
Έντυπη Μορφή (70 € + έξοδα αποστολής)
Printed Type (70 € + shipping)
pharmakonpress[at]pharmakonpress[.]gr

 

Προσθέστε στους σελιδοδείκτες το μόνιμο σύνδεσμο.

Τα σχόλια είναι απενεργοποιημένα.